[HTML] mdpi.com

[HTML][HTML] A review of FLT3 kinase inhibitors in AML

C Negotei, A Colita, I Mitu, AR Lupu… - Journal of Clinical …, 2023 - mdpi.com
Acute myeloid leukemia (AML) is a highly aggressive illness distinguished by the
accumulation of abnormal hematopoietic precursors in both the bone marrow and peripheral …
被引用次数：7 相关文章

A Review of FLT3 Kinase Inhibitors in AML

C Negotei, A Colita, I Mitu, AR Lupu… - Journal of clinical …, 2023 - pubmed.ncbi.nlm.nih.gov
Acute myeloid leukemia (AML) is a highly aggressive illness distinguished by the
accumulation of abnormal hematopoietic precursors in both the bone marrow and peripheral …

A Review of FLT3 Kinase Inhibitors in AML.

C Negotei, A Colita, I Mitu, AR Lupu… - Journal of Clinical …, 2023 - europepmc.org
Acute myeloid leukemia (AML) is a highly aggressive illness distinguished by the
accumulation of abnormal hematopoietic precursors in both the bone marrow and peripheral …
[HTML] nih.gov

[HTML][HTML] A Review of FLT3 Kinase Inhibitors in AML

C Negotei, A Colita, I Mitu, AR Lupu… - Journal of Clinical …, 2023 - ncbi.nlm.nih.gov
Acute myeloid leukemia (AML) is a highly aggressive illness distinguished by the
accumulation of abnormal hematopoietic precursors in both the bone marrow and peripheral …

A Review of FLT3 Kinase Inhibitors in AML.

C Negotei, A Colita, I Mitu, AR Lupu… - Journal of Clinical …, 2023 - search.ebscohost.com
Acute myeloid leukemia (AML) is a highly aggressive illness distinguished by the
accumulation of abnormal hematopoietic precursors in both the bone marrow and peripheral …

A Review of FLT3 Kinase Inhibitors in AML

C Negotei, A Colita, I Mitu, AR Lupu… - Journal of Clinical …, 2023 - search.proquest.com
Acute myeloid leukemia (AML) is a highly aggressive illness distinguished by the
accumulation of abnormal hematopoietic precursors in both the bone marrow and peripheral …